Skip to main content
Premium Trial:

Request an Annual Quote

Bioke, Trinean Ink Distribution Agreement

NEW YORK (GenomeWeb News) – Bioké has signed an agreement to distribute Trinean products in the Netherlands and Germany, the firms announced today.

Trinean's Xpose 'Touch & Go" platform is for quantifying DNA, RNA, and proteins, while the DropSense96 instrument quantifies DNA, RNA, and proteins without dyes in a microvolume 96-well format.

Bioké, based in Leiden, the Netherlands, is a cell signaling technology firm. "The addition of high quality Trinean products in the Bioké portfolio strengthens our ability to provide complete solutions to customers in academic institutions, hospitals, and in the pharmaceutical and biotechnology industries," Bioké Director of Sales and Operations Koos Kranenborg said in a statement.

Ghent, Belgium-based Trinean on Thursday announced a deal to supply its instruments to Bayer CropScience for that firm's molecular breeding program.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.